The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina

被引:12
|
作者
Ferrante, Daniel [1 ]
Konfino, Jonatan [1 ]
Mejia, Raul [2 ]
Coxson, Pamela [3 ]
Moran, Andrew [4 ]
Goldman, Lee [5 ]
Perez-Stable, Eliseo J. [3 ]
机构
[1] Minist Salud Nac, Buenos Aires, DF, Argentina
[2] Ctr Estudios Estado & Soc, Buenos Aires, DF, Argentina
[3] Univ Calif San Francisco, Dept Med, Div Med Gen Interna, San Francisco, CA USA
[4] Columbia Univ, Dept Med, Div Med Gen Interna, New York, NY USA
[5] Columbia Univ, Colegio Med & Cirujanos, New York, NY USA
关键词
Sodium; dietary; cardiovascular diseases; cost-benefit analysis; Argentina; CORONARY-HEART-DISEASE; BLOOD-PRESSURE; POLICY MODEL; RISK-FACTORS; MYOCARDIAL-INFARCTION; LATIN-AMERICAN; HYPERTENSION; SODIUM; STROKE; METAANALYSIS;
D O I
10.1590/S1020-49892012001000005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Estimate the cost-utility ratio of an intervention to reduce dietary salt intake in people over the age of 35 in Argentina. Methods. The intervention consisted of reducing salt content in food by 5% to 25%. A simulation model was used to measure the impact of policies on heart disease in order to predict incidence, prevalence, mortality, and cost trends for heart and cerebrovascular disease in the population aged 35-84. The intervention modeled the impact and costs of a 3-gram reduction in dietary salt intake by reducing the amount of salt in processed food and salt added to food by the participants themselves over a 10-year period. Changes in event occurrence during this period and gains in quality-adjusted life years (QALY) were estimated in high-and low-impact scenarios. Results. The intervention generated a net savings of US$ 3 765 million and a gain of 656 657 QALYs in the high-impact scenario and a savings of US$ 2 080 million and 401 659 QALY in the low-impact scenario. The result would be reductions in the incidence of heart disease (24.1%), acute myocardial infarction (21.6%), and stroke (20.5%), as well as in mortality from heart disease (19.9%) and all causes (6.4%). Benefits were observed for all age groups and both genders. Conclusions. Implementing this strategy to reduce salt intake would produce a very positive health impact, both in QALY gains and savings in economic resources.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 41 条
  • [21] Cost-utility analysis for pegaptanib in age-related macular degeneration in the UK: The impact of demographic and disease characteristics
    Wolowacz, S.
    Roskell, N.
    Maciver, F.
    Kelly, S.
    VALUE IN HEALTH, 2006, 9 (06) : A370 - A370
  • [22] A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH)
    Tam-Tham, Helen
    Clement, Fiona
    Hemmelgarn, Brenda R.
    Manns, Braden J.
    Klarenbach, Scott W.
    Tonelli, Marcello
    Tsuyuki, Ross T.
    Al Hamarneh, Yazid N.
    Penko, Joanne
    Weaver, Colin G. W.
    Au, Flora
    Weaver, Robert G.
    Jones, Charlotte A.
    McBrien, Kerry A.
    VALUE IN HEALTH, 2019, 22 (10) : 1128 - 1136
  • [23] Cost-effectiveness and cost-utility of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and tricyclic antidepressants in depression with comorbid cardiovascular disease
    Pan, Yi-Ju
    Kuo, Kuei-Hong
    Chan, Hung-Yu
    McCrone, Paul
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 54 : 70 - 78
  • [24] An Australian cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease: implications of incorporating fracture incidence
    Khalafallah, Alhossain
    Abel, Sean
    Pollock, Richard
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 251 - 251
  • [25] Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand
    Deerochanawong, Chaicharn
    Vareesangthip, Kriengsak
    Piyayotai, Dilok
    Thongsuk, Dittaya
    Pojchaijongdee, Nuch
    Permsuwan, Unchalee
    DIABETES THERAPY, 2021, 12 (07) : 1947 - 1963
  • [26] The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial
    aan de Stegge, Wouter B.
    Mejaiti, Nora
    van Netten, Jaap J.
    Dijkgraaf, Marcel G. W.
    van Baal, Jeff G.
    Busch-Westbroek, Tessa E.
    Bus, Sicco A.
    TRIALS, 2018, 19
  • [27] The cost-effectiveness and cost-utility of at-home infrared temperature monitoring in reducing the incidence of foot ulcer recurrence in patients with diabetes (DIATEMP): study protocol for a randomized controlled trial
    Wouter B. aan de Stegge
    Nora Mejaiti
    Jaap J. van Netten
    Marcel G. W. Dijkgraaf
    Jeff G. van Baal
    Tessa E. Busch-Westbroek
    Sicco A. Bus
    Trials, 19
  • [28] Seasonal variation in blood pressure and its impact on target organ damage and cardiovascular disease incidence
    Narita, Keisuke
    Kario, Kazuomi
    HYPERTENSION RESEARCH, 2023, 46 (07) : 1710 - 1711
  • [29] Seasonal variation in blood pressure and its impact on target organ damage and cardiovascular disease incidence
    Keisuke Narita
    Kazuomi Kario
    Hypertension Research, 2023, 46 : 1710 - 1711
  • [30] A COST-UTILITY ANALYSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND IRON DEFICIENCY ANEMIA IN THE NETHERLANDS: REDUCED HYPOPHOSPHATEMIA AND FRACTURE INCIDENCE WITH FERRIC DERISOMALTOSE VERSUS FERRIC
    Oron, U.
    Koek, G.
    Fijn, R.
    Pollock, R.
    VALUE IN HEALTH, 2024, 27 (12) : S116 - S116